Special radionuclide production activities – recent developments at QST and throughout Japan

Kotaro Nagatsu, Tomoyuki Ohya, Honoka Obata, Kazutoshi Suzuki, Ming-Rong Zhang

doi:10.1515/ract-2021-1124

Special radionuclide production activities – recent developments at QST and throughout Japan

DOI Web Site Web Site 被引用文献1件

Kotaro Nagatsu

Department of Advanced Nuclear Medicine Sciences , Institute for Quantum Medical Sciences (iQMS), National Institutes for Quantum Science and Technology (QST) , 4-9-1 Anagawa, Inage , Chiba 263-8555 , Japan
Tomoyuki Ohya

Department of Advanced Nuclear Medicine Sciences , Institute for Quantum Medical Sciences (iQMS), National Institutes for Quantum Science and Technology (QST) , 4-9-1 Anagawa, Inage , Chiba 263-8555 , Japan
Honoka Obata

Department of Advanced Nuclear Medicine Sciences , Institute for Quantum Medical Sciences (iQMS), National Institutes for Quantum Science and Technology (QST) , 4-9-1 Anagawa, Inage , Chiba 263-8555 , Japan
Kazutoshi Suzuki

Department of Advanced Nuclear Medicine Sciences , Institute for Quantum Medical Sciences (iQMS), National Institutes for Quantum Science and Technology (QST) , 4-9-1 Anagawa, Inage , Chiba 263-8555 , Japan
Ming-Rong Zhang

Department of Advanced Nuclear Medicine Sciences , Institute for Quantum Medical Sciences (iQMS), National Institutes for Quantum Science and Technology (QST) , 4-9-1 Anagawa, Inage , Chiba 263-8555 , Japan

抄録

<jats:title>Abstract</jats:title> <jats:p>National Institutes for Quantum Science and Technology (QST), formerly known as the National Institute of Radiological Sciences (NIRS), has been engaged in work on radiopharmaceutical science using cyclotrons since 1974. Eight pioneering researchers founded the basis of this field of research at NIRS, and to the present, many researchers and technicians have accumulated both scientific and technical achievements, as well as inherited the spirit of research. Besides, in recent years, we have developed production systems with AVF-930 cyclotron for various ‘non-standard’ radioisotopes applied in both diagnosis and therapy. Here, we review the past 50 years of our activities on radioisotope and radiopharmaceutical development, as well as more recent activities.</jats:p>